Nurix Therapeutics Inc (NRIX)

Cost of Revenue

$94.76M

TTM · Period ending: · USD

NRIX logo

NRIX Cost of Revenue

Latest reported$94.76M
NRIX TTM Cost of Revenue ($45.03M → $94.76M)
High-resolution chart · PNG

NRIX cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Nurix Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
94,757,000
97,618,000
171,864,000
157,390,000
219,983,000
270,464,000
241,290,000
221,632,000
204,121,000
196,496,000
193,337,000
189,148,000
185,541,000
185,446,000
187,176,000
184,497,000
174,922,000
158,067,000
136,568,000
116,434,000
100,348,000
88,381,000
76,529,000
66,493,000
58,872,000
50,941,000
47,558,000
45,025,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.